The present invention relates to lipid-substituted amino 1,2- and 1,3-diol compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.
本发明涉及脂质取代的
氨基1,2-和1,3
-二醇化合物,包括含有此类化合物的药物组合物,以及此类化合物在治疗方法或治疗炎症性疾病和某些与炎症信号传导过程相关的神经系统疾病中的用途,包括但不限于错误折叠蛋白。